Home›Companies›Healthcare›RapidAI

iSchemaView, Inc.

Medical imaging software helps healthcare teams assess patients.

Updated Nov 9, 2026·Latest SEC filing Aug 14, 2026·Suggest an edit

About RapidAI

RapidAI is a private company based in Menlo Park, California. It has reported $100,000,000 raised in two offerings on Form D since August 2023. Its chief executive is Karim Karti.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 17, 2026Aug 14, 2026$25,000,000fully sold1$25.0MDebt, Options, Securities on exerciseRule 506(b)Form D ↗
Jul 20, 2023Aug 2, 2023amended Aug 14, 2026$75,000,000of $75.0M target5$15.0MEquity, Options, Securities on exerciseRule 506(b)Form D/A ↗3 earlier filings
Total, two offerings$100,000,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on RapidAI's Form D filed Aug 14, 2026.

Gregory Albers
Gregory Albers
Chairman, Co-Founder & Scientific Lead
DS
David Stoffel
Chief Business Officer
BR
Brendan Renehan
Director, Vista Credit Partners
ED
Erol Dervis
Head of Direct Investment, Lennertz & Co, director
KK
Karim Karti
Chief Executive Officer and director
JD
John Drew
Director
MB
Mark Brandin
Managing Director, Brandin & Assoc
RB
Roland Bammer
Co-Founder & Technical Advisor, director

Sources

  1. SECiSchemaView, Inc. Form D/A, filed Sep 4, 2025
  2. SECiSchemaView, Inc. Form D/A, filed Aug 1, 2024
  3. SECiSchemaView, Inc. Form D, filed Aug 2, 2023
  4. SECiSchemaView, Inc. filing history
  5. CompanyPrivacy policy
  6. CompanyAbout RapidAI
  7. CompanyLeadership
  8. ResearchFDA: iSchemaView RAPID